Neurovascular Devices Market on Track to Hit $12.84 Billion Globally by 2034

Neurovascular Devices Market Size Worth USD 12.84 Billion by 2034 | CAGR: 5.9%


The neurovascular devices market size is expected to reach USD 12.84 Billion by 2034, according to a new study by Polaris Market Research. The report “Neurovascular Devices Market Share, Size, Trends, Industry Analysis Report: By Device Type, By Application, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Neurovascular devices are essential for the diagnosis and treatment of ischemic stroke, cerebral aneurysms, and other complex neurovascular disorders, allowing precise navigation and targeted therapy within the brain’s vascular system.

Market growth is primarily driven by the rising prevalence of neurovascular disorders, increasing preference for minimally invasive surgeries over open surgery, and continuous technological advancements that enhance safety and procedural efficacy.

Neurovascular Devices Market Report Highlights

  • Based on device type, the embolization devices segment dominated the market in 2024, driven by widespread use in aneurysm occlusion and arteriovenous malformation treatment, along with favorable safety and clinical outcomes.
  • Based on application, the ischemic stroke segment dominated the market in 2024, fueled by high prevalence of stroke cases and strong adoption of mechanical thrombectomy and other endovascular procedures.
  • By end user, hospitals held the largest market share in 2024, owing to the advanced neurointerventional infrastructure, specialized neurological teams, and comprehensive stroke care facilities.
  • North America held the dominant share in 2024, fueled by advanced healthcare infrastructure, early adoption of innovative devices, and high prevalence of stroke and aneurysms.
  • Asia Pacific is expected to grow at the fastest CAGR, driven by expanding healthcare infrastructure, rising awareness of stroke intervention, and adoption of advanced neurovascular treatments in countries such as China and India.
  • Key players in the global market include Medtronic plc, Stryker Corporation, Penumbra, Inc., Terumo Corporation, MicroPort Scientific Corporation, Balt Group SAS, Kaneka Corporation, Johnson & Johnson, Acandis GmbH, phenox GmbH, Rapid Medical Ltd., and Asahi Intecc Co., Ltd.

Request a free sample copy or read the full market insights: Neurovascular Devices Market

Polaris Market Research has segmented the market report based on device type, application, end user, and region:

By Device Type Outlook (Revenue, USD Billion, 2020–2034)

  • Stenting Systems
  • Embolization Devices
  • Neurothrombectomy Devices
  • Support Devices

By Application Outlook (Revenue, USD Billion, 2020–2034)

  • Cerebral Aneurysms
  • Ischemic Stroke
  • Other Application

By End User Outlook (Revenue, USD Billion, 2020–2034)

  • Hospitals
  • Specialty Clinics
  • Other End User

By Regional Outlook (Revenue, USD Billion, 2020–2034)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Malaysia
    • South Korea
    • Indonesia
    • Australia
    • Vietnam
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Israel
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America